Nu-Horizen Metchem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-01-2025
- Paid Up Capital ₹ 3.55 Cr
as on 09-01-2025
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
as on 09-01-2025
- Satisfied Charges ₹ 18.49 Cr
as on 09-01-2025
- Revenue 631.71%
(FY 2022)
- Profit 1176.04%
(FY 2022)
- Ebitda 94.09%
(FY 2022)
- Net Worth 76.49%
(FY 2022)
- Total Assets 30.17%
(FY 2022)
About Nu-Horizen Metchem
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.55 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹18.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Agrawal, Adarsh Agrawal, and Tarun Agrawal serve as directors at the Company.
- CIN/LLPIN
U24304JH2018PTC011285
- Company No.
011285
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Singhbhum, Jharkhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nu-Horizen Metchem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adarsh Agrawal  | Managing Director | 19-Apr-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarun Agrawal | Director | 10-Dec-2021 | Current |
| Rajendra Agrawal | Director | 19-Apr-2018 | Current |
Financial Performance of Nu-Horizen Metchem.
Nu-Horizen Metchem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 631.71% increase. The company also saw a substantial improvement in profitability, with a 1176.04% increase in profit. The company's net worth Soared by an impressive increase of 76.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nu-Horizen Metchem?
In 2023, Nu-Horizen Metchem had a public holding of 6.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- G.Raj Corporate Consultants Private LimitedActive 12 years 11 months
Rajendra Agrawal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Feb 2024 | ₹15.00 Cr | Open |
Others Creation Date: 02 Nov 2023 | ₹8.00 Cr | Satisfied |
Canara Bank Creation Date: 31 Dec 2020 | ₹10.49 Cr | Satisfied |
How Many Employees Work at Nu-Horizen Metchem?
Unlock and access historical data on people associated with Nu-Horizen Metchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nu-Horizen Metchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nu-Horizen Metchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
